Lec2 Flashcards

1
Q

What are the 4 major steps in drug development?

A
  • Synthesis/discovery of a new drug,
  • Safety/ effectiveness evaluation,
  • Submission and review of the new animal drug application (NADA),
  • Postmarketing surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Preliminary Studies

A

determine if the drug produces the intended effect and if toxic side effects are produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Preclinical studies

A

If preliminary studies produce satisfactory results and determine safety and effectiveness; Includes short and long term toxicity studies

Also includes special tests such as immediate drug reactions, organ system damage, reproductive effects, carcinogenicity, and teratogenicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Investigational New Animal Drug Application (INAD)

A

is submitted to the FDA upon sufficient animal data to demonstrate safety and effectiveness

The FDA reviews the INAD application and responds within 30 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Target species

A

(species intended for use) clinical trials are then conducted to determine safety, toxic/adverse side effects

Studies on shelf life and drug stability are also conducted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

New Animal Drug Application (NADA)

A

filed with the FDA subsequent to satisfactory clinical trials

Approval and license for manufacture are granted

The company and FDA monitor the drug as long as it is manufactured

Drugs intended for use in food - producing animals must also be tested for consumer safety and be free of drug residues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drug Toxicity Evaluation

A

Drugs must also be tested to determine if they cause toxic side effects

Need to know the dose at which organ/tissue damage occurs, that may if dose is high enough result in permanent injury or death

Must also determine the dose of drug that produces desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effective Dose - 50 (ED 50)

A

the dose of test drug that produces a desired effect in 50 percent of the animals tested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lethal Dose - 50 (LD 50)

A

dose of test drug that kills 50 percent of the animals tested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Therapeutic Index (TI)

A

the relationship between a drug’s ability to achieve the desired effect compared with its tendency to produce toxic/lethal effects or “margin of safety.” It is the drug dosage or dose that produces the desired effect with minimal or no signs of toxicity. = LD50/ED50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is a Safer TI a high or low number?

A

It is desirable to have a TI greater than 1 since the larger the number of the TI, the greater the margin of safety and the lower the TI number, the narrower the margin of safety thus greater caution must be used with the medication!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Systems-oriented screen

A

tests the drug’s effect on particular organ systems

Done after toxicity tests

Typically includes cardiovascular, respiratory, muscular, nervous and endocrine systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Long-term toxicity tests

A

(chronic studies)

Study toxic effects after repeated dosing over long periods of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Direct (Drug) Marketing

A

drugs purchased directly from the manufacturer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(Drug) Distributors

A

(wholesalers) – companies that purchase drugs from the manufacturer and resell to veterinarians

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Generic Companies

A

sell drugs no longer under patent protection

17
Q

Compare Generic drugs and patented drugs

A

Generic drugs must have the same bioequivalency or ability to produce similar blood levels as the original patented drug